Early stages of HIV replication: how to hijack cellular functions for a successful infection.

From the cell surface to the nucleus, the human immunodeficiency virus type 1 (HIV-1) will face multiple obstacles, crossing the plasma and nuclear membranes, but also finding its path within the cytoplasm in which elements from the cytoskeleton, organelles, and high a protein concentration, limit intracellular movements. At the same time, HIV-1 has to counteract cellular defenses--known as restriction factors--interfering with early steps of the virus cycle. Although the general outcomes of these early stages have been identified since several decades, the stepwise interactions taking place between cellular and viral components during this early journey, which will transform the incoming viral-RNA genome into a double-strand DNA competent for integration, remain largely unknown. In that sense, the uncoating process and the molecular basis of intracellular trafficking of preintegration complexes (PICs) are still poorly defined. Additionally, other key stages, which have been the focus of many reports, still require some clarifications, as is the case for the precise determinants of nuclear import of PICs. Finally, whereas the molecular mechanisms of integration, the last event of the early phase of retroviral life cycle, are now well understood, the choice of the integration site remains mysterious. Fully elucidating the early steps of HIV-1 replication is therefore crucial, not only for developing new antiretroviral drugs, but also for improving the design of lentiviral vectors for gene therapy. Since the mechanisms of HIV-1 entry and innate cell defenses were recently the topic of excellent reviews, we will focus here on uncoating and intracellular trafficking of HIV-1.

[1]  Pamela A. Silver,et al.  Identification of an Evolutionarily Conserved Domain in Human Lens Epithelium-derived Growth Factor/Transcriptional Co-activator p75 (LEDGF/p75) That Binds HIV-1 Integrase* , 2004, Journal of Biological Chemistry.

[2]  R. Siliciano,et al.  The multifactorial nature of HIV-1 latency. , 2004, Trends in molecular medicine.

[3]  S. Chattopadhyay,et al.  HIV-1 integration sites are flanked by potential MARs that alone can act as promoters. , 2004, Biochemical and biophysical research communications.

[4]  M. Llano,et al.  LEDGF/p75 Determines Cellular Trafficking of Diverse Lentiviral but Not Murine Oncoretroviral Integrase Proteins and Is a Component of Functional Lentiviral Preintegration Complexes , 2004, Journal of Virology.

[5]  A. Engelman,et al.  Identification and Characterization of a Functional Nuclear Localization Signal in the HIV-1 Integrase Interactor LEDGF/p75* , 2004, Journal of Biological Chemistry.

[6]  Marc C. Johnson,et al.  The stoichiometry of Gag protein in HIV-1 , 2004, Nature Structural &Molecular Biology.

[7]  P. Prevelige,et al.  Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange , 2004, Nature Structural &Molecular Biology.

[8]  M. Emerman,et al.  Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells , 2004, Journal of Virology.

[9]  P. Gönczy Centrosomes: Hooked on the Nucleus , 2004, Current Biology.

[10]  J. Ahringer,et al.  The C. elegans Hook Protein, ZYG-12, Mediates the Essential Attachment between the Centrosome and Nucleus , 2003, Cell.

[11]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[12]  F. Bushman Targeting Survival Integration Site Selection by Retroviruses and LTR-Retrotransposons , 2003, Cell.

[13]  Yuntao Wu,et al.  Early Transcription from Nonintegrated DNA in Human Immunodeficiency Virus Infection , 2003, Journal of Virology.

[14]  E. De Clercq,et al.  LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells* , 2003, Journal of Biological Chemistry.

[15]  E. Réal,et al.  Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8 , 2003, Journal of Cell Science.

[16]  M. Wilhelm,et al.  The central PPT of the yeast retrotransposon Ty1 is not essential for transposition. , 2003, Journal of molecular biology.

[17]  Ian F. Harrison,et al.  Nuclear import of HIV‐1 intracellular reverse transcription complexes is mediated by importin 7 , 2003, The EMBO journal.

[18]  D. Jans,et al.  Nuclear import of the pre-integration complex (PIC): the Achilles heel of HIV? , 2003, Current drug targets.

[19]  B. Peterlin,et al.  Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Chattopadhyay,et al.  Stimulation of Tat-independent transcriptional processivity from the HIV-1 LTR promoter by matrix attachment regions. , 2003, Nucleic acids research.

[21]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[22]  P. Prevelige,et al.  Identification of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry. , 2003, Journal of molecular biology.

[23]  Christof von Kalle,et al.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. , 2003, The New England journal of medicine.

[24]  Zeger Debyser,et al.  HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells* , 2003, The Journal of Biological Chemistry.

[25]  Einar Hallberg,et al.  Docking of HIV-1 Vpr to the Nuclear Envelope Is Mediated by the Interaction with the Nucleoporin hCG1* , 2002, The Journal of Biological Chemistry.

[26]  D. McDonald,et al.  Visualization of the intracellular behavior of HIV in living cells , 2002, The Journal of cell biology.

[27]  F. Bushman Targeting retroviral integration? , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  Takeshi Suzuki,et al.  New genes involved in cancer identified by retroviral tagging , 2002, Nature Genetics.

[29]  Paul Shinn,et al.  HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.

[30]  E. Bon,et al.  HIV-1 integrase interacts with yeast microtubule-associated proteins. , 2002, Biochimica et biophysica acta.

[31]  S. A. Chow,et al.  Correct integration mediated by integrase-LexA fusion proteins incorporated into HIV-1. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[32]  N. Pante,et al.  Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. , 2002, Molecular biology of the cell.

[33]  W. Greene,et al.  Dynamic Disruptions in Nuclear Envelope Architecture and Integrity Induced by HIV-1 Vpr , 2001, Science.

[34]  J. Canon,et al.  HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. , 2001, AIDS research and human retroviruses.

[35]  S. Goff Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways , 2001, The journal of gene medicine.

[36]  D. Voytas,et al.  Targeting of the Yeast Ty5 Retrotransposon to Silent Chromatin Is Mediated by Interactions between Integrase and Sir4p , 2001, Molecular and Cellular Biology.

[37]  B. Cullen Journey to the Center of the Cell , 2001, Cell.

[38]  M. Malim,et al.  HIV-1 infection requires a functional integrase NLS. , 2001, Molecular cell.

[39]  W. Greene,et al.  Human Immunodeficiency Virus Type 1 Nef Functions at the Level of Virus Entry by Enhancing Cytoplasmic Delivery of Virions , 2001, Journal of Virology.

[40]  M. Way,et al.  Viral transport and the cytoskeleton , 2001, Current Opinion in Cell Biology.

[41]  M. Bukrinsky,et al.  Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. , 2000, Journal of molecular biology.

[42]  Luc Montagnier,et al.  HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap , 2000, Cell.

[43]  S. King,et al.  The molecular anatomy of dynein. , 2000, Essays in biochemistry.

[44]  James W. Casey,et al.  Sequence and Transcriptional Analyses of the Fish Retroviruses Walleye Epidermal Hyperplasia Virus Types 1 and 2: Evidence for a Gene Duplication , 1999, Journal of Virology.

[45]  L. Selig,et al.  HEED, the Product of the Human Homolog of the Murineeed Gene, Binds to the Matrix Protein of HIV-1* , 1999, The Journal of Biological Chemistry.

[46]  H. Gelderblom,et al.  Efficient HIV‐1 replication can occur in the absence of the viral matrix protein , 1998, The EMBO journal.

[47]  O. Schwartz,et al.  Cytosolic Gag p24 as an Index of Productive Entry of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[48]  J. Garcia,et al.  Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems. , 1998, Virology.

[49]  G. Blobel,et al.  Viral protein R regulates nuclear import of the HIV‐1 pre‐integration complex , 1998, The EMBO journal.

[50]  P. Silver,et al.  HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. , 1998, Genes & development.

[51]  K. Bomsztyk,et al.  The product of the murine homolog of the Drosophila extra sex combs gene displays transcriptional repressor activity , 1997, Molecular and cellular biology.

[52]  M. Malim,et al.  HIV‐1 infection of non‐dividing cells: evidence that the amino‐terminal basic region of the viral matrix protein is important for Gag processing but not for post‐entry nuclear import , 1997, The EMBO journal.

[53]  S. A. Chow,et al.  Characterization of feline immunodeficiency virus integrase and analysis of functional domains. , 1997, Virology.

[54]  S. A. Chow,et al.  Central Core Domain of Retroviral Integrase Is Responsible for Target Site Selection* , 1997, The Journal of Biological Chemistry.

[55]  F. Bushman,et al.  HIV-1 cDNA Integration: Requirement of HMG I(Y) Protein for Function of Preintegration Complexes In Vitro , 1997, Cell.

[56]  A. Saïb,et al.  Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step , 1997, Journal of virology.

[57]  P. Sharp,et al.  Nuclear import and cell cycle arrest functions of the HIV‐1 Vpr protein are encoded by two separate genes in HIV‐2/SIV(SM). , 1996, The EMBO journal.

[58]  F. Lori,et al.  HIV-1 Protein Expression from Synthetic Circles of DNA Mimicking the Extrachromosomal Forms of Viral DNA (*) , 1996, The Journal of Biological Chemistry.

[59]  D. Voytas,et al.  The Saccharomyces retrotransposon Ty5 integrates preferentially into regions of silent chromatin at the telomeres and mating loci. , 1996, Genes & development.

[60]  V. Vogt,et al.  Nucleotide sequence and protein analysis of a complex piscine retrovirus, walleye dermal sarcoma virus , 1995, Journal of virology.

[61]  E. Freed,et al.  Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection , 1995, Journal of virology.

[62]  G. Crabtree,et al.  Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. , 1994, Science.

[63]  H. Buc,et al.  HIV-1 reverse transcription. A termination step at the center of the genome. , 1994, Journal of molecular biology.

[64]  W. Greene,et al.  The HIV-1 nef gene acts as a positive viral infectivity factor. , 1994, Trends in microbiology.

[65]  M. Emerman,et al.  Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus , 1994, Journal of virology.

[66]  M. Emerman,et al.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells , 1993, Nature.

[67]  P. Brown,et al.  Integration of murine leukemia virus DNA depends on mitosis. , 1993, The EMBO journal.

[68]  J. Kupiec,et al.  Further characterization of the gapped DNA intermediates of human spumavirus: evidence for a dual initiation of plus-strand DNA synthesis. , 1991, The Journal of general virology.

[69]  M. Marsh,et al.  Human immunodeficiency virus infection of CD4‐bearing cells occurs by a pH‐independent mechanism. , 1988, The EMBO journal.

[70]  M. Bukrinsky A Hard Way to the Nucleus , 2004, Molecular medicine.

[71]  Nitin K Saksena,et al.  Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy. , 2003, AIDS reviews.

[72]  W. Greene,et al.  Slipping through the door: HIV entry into the nucleus. , 2002, Microbes and infection.